These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 5304081)

  • 1. 5-hydroxyindoleacetic acid in cerebrospinal fluid after administration of 5-hydroxytryptophan I.
    Andersson H; Roos BE
    Acta Pharmacol Toxicol (Copenh); 1968; 26(4):293-7. PubMed ID: 5304081
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-hydroxyindoleacetic acid in ventricular cerebrospinal fluid and brain of normal and hydrocephalic dogs after administration of 5-hydroxytryptophan. II.
    Andersson H; Roos BE
    Acta Pharmacol Toxicol (Copenh); 1968; 26(6):531-8. PubMed ID: 5305087
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of reserpine, L-dopa and 5-hydroxytryptophan on 5-hydroxyindoleacetic and homovanillic acids in cerebrospinal fluid, behaviour and EEG in cats.
    Buckingham RL; Radulovacki M
    Neuropharmacology; 1976 Jul; 15(7):389-92. PubMed ID: 1086441
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental studies on monoamine metabolites in hydrocephalus.
    Andersson H; Roos BE
    Acta Neurol Scand; 1967; 43(S31):72-3. PubMed ID: 5300372
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of injections of D,L-5-hydroxytryptophan on the efflux of endogenous serotonin and 5-hydroxyindoleacetic acid from a synaptosomal fraction.
    Penn PE; McBride WJ
    J Neurochem; 1977 Apr; 28(4):765-9. PubMed ID: 302324
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of 5-hydroxyindoles in various regions of dog brain and cerebrospinal fluid.
    Eccleston D; Ashcroft GW; Moir AT; Parker-Rhodes A; Lutz W; O'Mahoney DP
    J Neurochem; 1968 Sep; 15(9):947-57. PubMed ID: 5303059
    [No Abstract]   [Full Text] [Related]  

  • 7. 5-Hydroxytryptophan-induced cortisol response and CSF 5-HIAA in depressed patients.
    Koyama T; Lowy MT; Meltzer HY
    Am J Psychiatry; 1987 Mar; 144(3):334-7. PubMed ID: 2435178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of L-5-hydroxytryptophan and L-5-hydroxytryptophan inosinate as agents for increasing brain serotonin formation in rats.
    Fuller RW; Snoddy HD; Robertson DW
    Res Commun Chem Pathol Pharmacol; 1992 Apr; 76(1):121-4. PubMed ID: 1381513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential uptake, metabolism and behavioral effects of the D and L isomers of 5-hydroxytryptophan.
    Penn PE; McBride WJ; Hingtgen JN; Aprison MH
    Pharmacol Biochem Behav; 1977 Dec; 7(6):515-8. PubMed ID: 304218
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased release of brain serotonin reduces vulnerability to ventricular fibrillation in the cat.
    Lehnert H; Lombardi F; Raeder EA; Lorenzo AV; Verrier RL; Lown B; Wurtman RJ
    J Cardiovasc Pharmacol; 1987 Oct; 10(4):389-97. PubMed ID: 2444791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p-Chlorophenylalanine: a specific depletor of brain serotonin.
    Koe BK; Weissman A
    J Pharmacol Exp Ther; 1966 Dec; 154(3):499-516. PubMed ID: 5297133
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of precursor loading in the cerebral metabolism of 5-hydroxyindoles.
    Moir AT; Eccleston D
    J Neurochem; 1968 Oct; 15(10):1093-108. PubMed ID: 5304606
    [No Abstract]   [Full Text] [Related]  

  • 13. Determination of 5-hydroxytryptophan, serotonin and 5-hydroxyindoleacetic acid in rat and human brain and biological fluids by reversed-phase high-performance liquid chromatography with electrochemical detection.
    Semerdjian-Rouquier L; Bossi L; Scatton B
    J Chromatogr; 1981 Nov; 218():663-70. PubMed ID: 6172438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotoninergic system in dementia of the Alzheimer type. Abnormal forms of 5-hydroxytryptophan and serotonin in cerebrospinal fluid.
    Volicer L; Langlais PJ; Matson WR; Mark KA; Gamache PH
    Arch Neurol; 1985 Dec; 42(12):1158-61. PubMed ID: 2415092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of conflict behavior with cinanserin, a serotonin antagonist: reversal of the effect with 5-hydroxytryptophan and alpha-methyltryptamine.
    Geller I; Hartmann RJ; Croy DJ; Haber B
    Res Commun Chem Pathol Pharmacol; 1974 Jan; 7(1):165-74. PubMed ID: 4544101
    [No Abstract]   [Full Text] [Related]  

  • 16. Circadian rhythms in serum and CSF cortisol of rhesus monkeys, and their modulation by timed injections of L-5-hydroxytryptophan.
    Umberkoman-Wiita B; Hansen S; Herbert J; Moore GF
    Brain Res; 1981 Oct; 222(2):235-52. PubMed ID: 6169395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid monoamine metabolites and peripheral decarboxylase inhibitors in parkinsonism.
    Chase TN
    Neurology; 1970 Dec; 20(12):Suppl:36-40. PubMed ID: 5312403
    [No Abstract]   [Full Text] [Related]  

  • 18. 5-hydroxytryptophan (5-HTP) in Down's syndrome.
    Partington MW; MacDonald MR
    Dev Med Child Neurol; 1971 Jun; 13(3):362-72. PubMed ID: 4255254
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of 5-hydroxytryptophan on serotonin in nerve endings.
    McBride WJ; Aprison MH; Hingtgen JN
    J Neurochem; 1974 Aug; 23(2):385-91. PubMed ID: 4547408
    [No Abstract]   [Full Text] [Related]  

  • 20. Simultaneous determination of tryptophan and its 5-hydroxy metabolites in human cerebrospinal fluid by reversed phase liquid chromatography with electrochemical detection.
    Laakso JT; Koskiniemi ML; Wahlroos O; Härkönen M
    Scand J Clin Lab Invest; 1983 Oct; 43(6):463-72. PubMed ID: 6197747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.